RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.

Front Cell Infect Microbiol · 2022 · PMC9807911 · PMID 36605129

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Antibody titers to CyRPA were higher when the antigens were administered in a 1:1:1 mass ratio, compared with the equimolar ratio regimen, although this difference did not reach statistical significance ( Figure 4C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.